0001104659-20-100107.txt : 20200828 0001104659-20-100107.hdr.sgml : 20200828 20200828151915 ACCESSION NUMBER: 0001104659-20-100107 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200827 FILED AS OF DATE: 20200828 DATE AS OF CHANGE: 20200828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Jeffrey Allen CENTRAL INDEX KEY: 0001500210 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 811-06565 FILM NUMBER: 201147538 MAIL ADDRESS: STREET 1: KING PHARMACEUTICALS, INC. STREET 2: 501 FIFTH STREET CITY: BRISTOL STATE: TN ZIP: 37620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEKLA LIFE SCIENCES INVESTORS CENTRAL INDEX KEY: 0000884121 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 043147016 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 100 FEDERAL STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6177728515 MAIL ADDRESS: STREET 1: 100 FEDERAL STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: H&Q LIFE SCIENCES INVESTORS DATE OF NAME CHANGE: 19920929 3 1 a3.xml 3 X0206 3 2020-08-27 1 0000884121 TEKLA LIFE SCIENCES INVESTORS HQL 0001500210 Bailey Jeffrey Allen C/O TEKLA LIFE SCIENCES INVESTORS 100 FEDERAL STREET, 19TH FLOOR BOSTON MA 02110 1 0 0 0 /s/ Jeffrey A. Bailey 2020-08-28